Lupus nephritis - who class III

Clinical trials for Lupus nephritis - who class III explained in plain language.

Never miss a new study

Get alerted when new Lupus nephritis - who class III trials appear

Sign up with your email to follow new studies for Lupus nephritis - who class III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

Experimental CAR-T therapy takes on Hard-to-Treat lupus nephritis

Disease control Stopped early

This early-phase trial is testing a personalized cell therapy called KYV-101 for people with lupus nephritis that hasn't responded to standard treatments. The therapy uses a patient's own immune cells, modified to target and destroy faulty B cells that drive the disease. Only 2 p…

Matched conditions: LUPUS NEPHRITIS - WHO CLASS III

Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Lupus nephritis - who class III

Get alerted when new Lupus nephritis - who class III trials appear

Experimental CAR-T therapy takes on Hard-to-Treat lupus nephritis